XtalPi helps drug companies find and develop new medicines faster by combining artificial intelligence, computer simulations, and automated lab robots. Its software predicts how molecules behave, and its robotic workstations carry out chemical experiments automatically. It also runs drug discovery projects for partners, from finding promising compounds to improving them.

Healthcare · Health Information Services · 2228.HK

What XtalPi Does & How It Makes Money (2228.HK)

Updated October 2026 · reflects XtalPi's latest reported financials

AI and robotics-powered drug discovery and chemistry research platform. It earns revenue by providing drug discovery and chemistry research solutions to pharmaceutical and biotech partners, and by selling or licensing its automation hardware and computational software tools.

XtalPi's story, moat and numbers — in a 3-minute visual book.

Explore XtalPi on TacticScale →

How XtalPi makes money

It earns revenue by providing drug discovery and chemistry research solutions to pharmaceutical and biotech partners, and by selling or licensing its automation hardware and computational software tools. It also takes part in strategic R&D collaborations, such as with Pfizer and DoveTree.

What XtalPi does

XtalPi Holdings (formerly QuantumPharm Inc., renamed in December 2024) is a Shenzhen-based research platform company founded in 2015 that works in Mainland China, the United States and other markets. It combines AI, cloud-based molecular simulation and laboratory automation to speed up drug discovery and chemistry research. Its tools include XmartChem automated synthesis workstations, ChemPlus solid dispensing devices, XFEP free-energy calculation software, the XMolGen generative chemistry tool and the PatSight patent structure extractor. Beyond tools, XtalPi offers end-to-end discovery services: hit discovery, hit and lead optimization, biology capabilities, peptide design via PepiX, focused compound libraries and XtalGazer solid-state research. Its partnerships include co-building an AI-driven molecular simulation platform with Pfizer, working with DoveTree on hard-to-drug targets, and developing oral small molecule therapeutics for a GPCR target with an international biopharmaceutical company.

Products & services

XmartChem intelligent synthesis workstation
XFEP cloud FEP calculation software
XMolGen generative chemistry tool
PepiX peptide generation
XtalGazer solid-state research
PatSight patent structure extraction

What is XtalPi worth?

Fair value: not published

A reliable owner-earnings fair value isn't available for this company yet — we'd rather say so than print a number we don't trust.

We show a fair value only when the method is trustworthy. See XtalPi on TacticScale →

Sector Healthcare Industry Health Information Services HQ China Ticker 2228.HK Official site

Related companies

WuXi AppTec (603259.SS) · Schrödinger (SDGR) · Zhejiang Jingxin Pharmaceutical (002020.SZ)

Understand XtalPi in 3 minutes →